Exagen Inc (NASDAQ: XGN) Podcast

Exagen Inc (NASDAQ: XGN)

Exagen Inc
News and interviews from Exagen Inc which trades on the NASDAQ under the symbol XGN. Exagen is dedicated to transforming the care continuum for patients suffering from debilitating and chronic autoimmune diseases by enabling timely differential diagnosis and optimizing therapeutic intervention. Exagen has developed and is commercializing a portfolio of innovative testing products under its AVISE® brand, several of which are based on our proprietary Cell-Bound Complement Activation Products, or CB-CAPs, technology.
Exagen Inc President & CEO, Ron Rocca Interview with TodaysStocks.com Host, Pat Bolland
TodaysStocks.com news host Pat Bolland interviews CEO Ron Rocca from Exagen Inc.     Exagen (NASDAQ: XGN) is a leading provider of autoimmune diagnostic, prognostic, and monitoring testing solutions.  Exagen is a patient focused, discovery driven organization built on the success of AVISE testing and is investing in its product pipeline to support patients throughout their autoimmune diagnosis and treatment. Exagen’s goal is to assist patients, physicians, and payors by enabling precision medicine. Exagen is located in San Diego County with clinical and research and development laboratories in Vista, CA.  Ron Rocca and Pat Bolland's discussion was centred on the Exagen Inc press release dated July 5, 2022 https://stockmkt.info/3yOyPzK  0:16 CAPSTONE Study  0:56 1st finding  1:14 2nd finding  1:58 3rd finding  2:30 4th finding  2:43 5th finding  3:00 Size of study  3:30 How long does the study take  4:45 Business side of things   Learn more about Exagen Inc. on their website www.Exagen.com
Jul 11, 2022
6 min
Exagen Inc President & CEO, Ron Rocca Interview with TodaysStocks.com Host, Pat Bolland
Exagen Inc. (NASDAQ: XGN) is a patient-focused and discovery-driven commercial-stage life sciences company, that aids patients and healthcare providers in the diagnosis, prognosis, and management of autoimmune conditions. A relentless pursuit for laboratory excellence has enabled Exagen to develop next-generation autoimmune testing to help empower physicians and improve patients' lives.   Learn more about Exagen Inc on their website https://exagen.com/  =================================================================  TodaysStocks.com Today's News for Tomorrows Investor   Find out more @ https://todaysstocks.com/    Want to book a CEO Interview with Pat Bolland? Click here↓   https://stockmkt.info/3wQaurn    Want to book a News Release Interview with Natalie Stoberman? Click here↓  https://stockmkt.info/3wRITY5    Follow us Facebook: https://www.facebook.com/TodaysStocksNow    Follow us on Twitter: https://twitter.com/TodaysStocksNow  ________________________________________________________________    TodaysStocks.com does not guarantee the accuracy or thoroughness of the information reported in the interviews it conducts. The opinions expressed in these interviews do not reflect the opinions of TodaysStocks.com and do not constitute investment advice. All readers and viewers are encouraged to perform their own due diligence.
May 31, 2022
6 min